This regulatory role of GFPT1 in modulating cell viability and apoptosis suggests that targeting GFPT1 could be a promising therapeutic strategy, particularly in metastatic or chemotherapy-resistant breast cancer. The gene discussed is GFPT1; the disease is breast cancer.